Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | M6PR | P20645 | 2/20 | 0.51 |
| ▸ | G6PD | P11413 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC5A2 | P31639 | 4/20 | 0.32 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16098706 | 1.00 | M6PR (0.51) | M6PRG6PDMEN1KMT2ASLC5A2 | |
| SCHEMBL16093664 | 1.00 | M6PR (0.51) | M6PRG6PDMEN1KMT2ASLC5A2 | |
| SCHEMBL15698043 | 0.79 | M6PR (0.56) | M6PRG6PDSYNJ2 | |
| SCHEMBL15700171 | 0.79 | M6PR (0.56) | M6PRG6PDSYNJ2 | |
| SCHEMBL19502333 | 0.79 | M6PR (0.56) | M6PRG6PDSYNJ2 | |
| SCHEMBL8615533 | 0.79 | M6PR (0.56) | M6PRG6PDSYNJ2 | |
| SCHEMBL20143964 | 0.79 | M6PR (0.56) | M6PRG6PDSYNJ2 | |
| SCHEMBL13072839 | 0.77 | M6PR (0.46) | M6PRG6PDMEN1KMT2ASYNJ2 | |
| SCHEMBL13929525 | 0.77 | M6PR (0.46) | M6PRG6PDMEN1KMT2ASYNJ2 | |
| SCHEMBL220693 | 0.74 | M6PR (0.42) | M6PRG6PDMEN1KMT2ASYNJ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170281772-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-10-05 | — | — | US | claimed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-20170281772-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-10-05 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |